SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Boston Scientific WATCHMAN FLX Pro Study Meets Primary Endpoints

Six-month data showed aspirin alone and reduced-dose NOAC each achieved non-inferiority to dual anti

BSX

Related stories